0001939796-24-000001.txt : 20241107 0001939796-24-000001.hdr.sgml : 20241107 20241107170509 ACCESSION NUMBER: 0001939796-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241107 DATE AS OF CHANGE: 20241107 EFFECTIVENESS DATE: 20241107 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RevOpsis Therapeutics, Inc. CENTRAL INDEX KEY: 0001939796 ORGANIZATION NAME: IRS NUMBER: 883217217 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-528924 FILM NUMBER: 241436940 BUSINESS ADDRESS: STREET 1: 4109 CHANDLERWOOD CITY: SPRINGFIELD STATE: IL ZIP: 62711 BUSINESS PHONE: 6462215178 MAIL ADDRESS: STREET 1: 4109 CHANDLERWOOD CITY: SPRINGFIELD STATE: IL ZIP: 62711 D 1 primary_doc.xml X0708 D LIVE 0001939796 RevOpsis Therapeutics, Inc. 4109 CHANDLERWOOD SPRINGFIELD IL ILLINOIS 62711 6462215178 DELAWARE None None Corporation true 2022 Ramanath Bhandari 4109 Chandlerwood Springfield IL ILLINOIS 62711 Executive Officer Ram Palanki 4190 Chandlerwood Springfield IL ILLINOIS 62711 Director Biotechnology Decline to Disclose 06b false 2024-10-24 false true SAFE (Simple Agreement for Future Equity) false 25000 Indefinite 575000 Indefinite false 4 0 0 0 false RevOpsis Therapeutics, Inc. Ramanath Bhandari Ramanath Bhandari Chief Executive Officer 2024-11-07